These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 39136020)

  • 1. Organoids: new frontiers in tumor immune microenvironment research.
    Yang Y; Cui J; Kong Y; Hou Y; Ma C
    Front Immunol; 2024; 15():1422031. PubMed ID: 39136020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoid Models of Tumor Immunology.
    Yuki K; Cheng N; Nakano M; Kuo CJ
    Trends Immunol; 2020 Aug; 41(8):652-664. PubMed ID: 32654925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment.
    Polak R; Zhang ET; Kuo CJ
    Nat Rev Cancer; 2024 Aug; 24(8):523-539. PubMed ID: 38977835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of organoids in creating immune microenvironments and treating gynecological tumors.
    Zhou LF; Liao HY; Han Y; Zhao Y
    J Transl Med; 2024 Sep; 22(1):856. PubMed ID: 39313812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoid Models for Precision Cancer Immunotherapy.
    Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
    Front Immunol; 2022; 13():770465. PubMed ID: 35450073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Derived Organoids for Precision Cancer Immunotherapy.
    Grönholm M; Feodoroff M; Antignani G; Martins B; Hamdan F; Cerullo V
    Cancer Res; 2021 Jun; 81(12):3149-3155. PubMed ID: 33687948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer organoids and their applications for precision cancer immunotherapy.
    Guan D; Liu X; Shi Q; He B; Zheng C; Meng X
    World J Surg Oncol; 2023 Oct; 21(1):343. PubMed ID: 37884976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.
    Picca F; Giannotta C; Tao J; Giordanengo L; Munir HMW; Botta V; Merlini A; Mogavero A; Garbo E; Poletto S; Bironzo P; Doronzo G; Novello S; Taulli R; Bersani F
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
    Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
    Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoids as an Enabler of Precision Immuno-Oncology.
    Zhao J; Fong A; Seow SV; Toh HC
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid Modeling of the Tumor Immune Microenvironment.
    Neal JT; Li X; Zhu J; Giangarra V; Grzeskowiak CL; Ju J; Liu IH; Chiou SH; Salahudeen AA; Smith AR; Deutsch BC; Liao L; Zemek AJ; Zhao F; Karlsson K; Schultz LM; Metzner TJ; Nadauld LD; Tseng YY; Alkhairy S; Oh C; Keskula P; Mendoza-Villanueva D; De La Vega FM; Kunz PL; Liao JC; Leppert JT; Sunwoo JB; Sabatti C; Boehm JS; Hahn WC; Zheng GXY; Davis MM; Kuo CJ
    Cell; 2018 Dec; 175(7):1972-1988.e16. PubMed ID: 30550791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Cancer Medicine: An Organoid Approach.
    Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
    Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
    Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
    OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoid technology and applications in cancer immunotherapy and precision medicine.
    Homicsko K
    Curr Opin Biotechnol; 2020 Oct; 65():242-247. PubMed ID: 32603978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients.
    Jeong SR; Kang M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal multicellular organoids to study colorectal cancer.
    Idris M; Alves MM; Hofstra RMW; Mahe MM; Melotte V
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188586. PubMed ID: 34216725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of organoids in precision immunotherapy of lung cancer (Review).
    Tian H; Ren J; Mou R; Jia Y
    Oncol Lett; 2023 Nov; 26(5):484. PubMed ID: 37818130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.